Department of Neurobiology, Division of Nursing, Care sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Department of Global Public Health, Karolinska Institutet, Research Group "Epidemiology of Psychiatric Conditions, Substance use and Social Environment", Stockholm, Sweden.
PLoS One. 2024 Sep 4;19(9):e0308924. doi: 10.1371/journal.pone.0308924. eCollection 2024.
Living with chronic pain is associated with substantial suffering and high societal costs. Patient reported outcomes (PROM's) and cellular ageing should be considered in pain management. The aim of this study was to explore correlations of PROM's and cellular ageing (telomere length [TL] and telomerase activity [TA]) amongst patients with chronic non-malignant pain. This was an explorative pilot study with cross-sectional design and recruitment was done at two pain rehabilitation facilities in Sweden, with inpatient setting/integrative care and outpatient setting/multimodal care, respectively. Eighty-four patients were enrolled by referral to pain rehabilitation in Sweden. The main outcome measures collected after admission in addition to TL and TA were the following PROMs: Numerical Rating Scale (NRS), Chronic Pain Acceptance Questionnaire (CPAQ), Hospital Anxiety and Depression Scale (HADS), Five Facets Mindfulness Questionnaire (FFMQ), WHO Quality of Life-Spiritual, Religious and Personal Beliefs (WHOQoL-SRPB) and EuroQol 5 Dimensions (EQ-5D). All the PROM's showed evidence of poor overall health status among the participants. TL correlated negatively with HADS score (r = -.219, p = .047) and positively with WHOQoL-SRPB (r = .224, p = .052). TL did not correlate with any of the pain measures. TA correlated positively with pain spread (r = .222, p = .049). A mediation of the direct effect of spiritual well-being on TL by anxiety and depression could be shown (b = 0.008; p = .045). The correlations between TL and SRPB and anxiety and depression suggest some importance of emotional and SRPB dimensions in pain management, with implications for cellular aging, which may warrant further study. Trial registration: ClinicalTrials.gov Identifier: NCT02459639.
患有慢性疼痛会带来巨大的痛苦和高昂的社会成本。在疼痛管理中应考虑患者报告的结果(PROM)和细胞衰老。本研究旨在探讨慢性非恶性疼痛患者的 PROM 和细胞衰老(端粒长度[TL]和端粒酶活性[TA])之间的相关性。这是一项探索性的试点研究,采用了横断面设计,在瑞典的两家疼痛康复机构进行了招募,分别为住院综合治疗和门诊多模式治疗。通过向瑞典的疼痛康复机构转介,共招募了 84 名患者。除了 TL 和 TA 之外,在入院后还收集了以下 PROM:数字评分量表(NRS)、慢性疼痛接受问卷(CPAQ)、医院焦虑和抑郁量表(HADS)、五因素正念问卷(FFMQ)、世界卫生组织生活质量-精神、宗教和个人信仰(WHOQoL-SRPB)和欧洲五维健康量表(EQ-5D)。所有 PROM 均表明参与者的整体健康状况不佳。TL 与 HADS 评分呈负相关(r = -.219,p =.047),与 WHOQoL-SRPB 呈正相关(r =.224,p =.052)。TL 与任何疼痛测量均无相关性。TA 与疼痛扩散呈正相关(r =.222,p =.049)。可以证明焦虑和抑郁对 TL 与精神幸福感之间的直接影响具有中介作用(b = 0.008;p =.045)。TL 与 SRPB 和焦虑抑郁之间的相关性表明,情绪和 SRPB 维度在疼痛管理中具有一定的重要性,这可能与细胞衰老有关,值得进一步研究。试验注册:ClinicalTrials.gov 标识符:NCT02459639。